Use of a false recognition paradigm in an Alzheimer's disease clinical trial: A pilot study

American Journal of Alzheimer's Disease and other Dementias

Volumn 17, Issue 2, 2002, Pages 93-100

  Budson, Andrew E ^a,b   Michalska, Kalina J ^b   Rentz, Dorene M ^a,b   Joubert, Claire C ^a   Daffner, Kirk R ^a,b   Schacter, Daniel L ^c   Sperling, Reisa A ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c HARVARD UNIVERSITY   (United States)

Author keywords

Alzheimer's disease; Memory; Neotrofin

Indexed keywords

LETEPRINIM; PLACEBO;

AGED; ALZHEIMER DISEASE; ARTICLE; ASSOCIATIVE MEMORY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG MECHANISM; FEMALE; HUMAN; MALE; MEMORY; MEMORY CONSOLIDATION; RANDOMIZED CONTROLLED TRIAL; RECALL; RECOGNITION; STANDARD; VISUAL MEMORY; WORD RECOGNITION;

EID: 0036309620     PISSN: 15333175     EISSN: None     Source Type: Journal    
DOI: 10.1177/153331750201700204     Document Type: Article

References (38)

1. Delusional misidentification in Alzheimer's disease: A summary of clinical and biological aspects
2. Clinical features and pharmacologic treatment of behavioral symptoms of Alzheimer's disease
3. On the prediction of occurrence of particular verbal intrusions in immediate recall
4. Creating false memories: Remembering words not presented in lists
5. When true recognition suppresses false recognition: Evidence from amnesic patients
6. Fuzzy-trace theory: An interim synthesis
7. The cognitive neuro-science of constructive memory
8. Fuzzy-trace theory and children's false memories
9. Memory illusions: Recalling, recognizing, and recollecting events that never occurred
10. The neuropsychology of memory illusions: False recall and recognition in amnesic patients
11. Veridical and false memories in healthy older adults and in dementia of the Alzheimer's type
12. Semantic, phonological, and hybrid veridical and false memories in healthy adults and in dementia of the Alzheimer's type
13. When false recognition is unopposed by true recognition: Gist-based memory distortion in Alzheimer's disease
14. Perceptual false recognition in Alzheimer's disease
15. False recognition of pictures versus words in Alzheimer's disease: The distinctiveness heuristic
16. Recognizing identical vs. similar categorically related common objects: Further evidence for degraded gist-representations in amnesia
17. Illusory memories in amnesic patients: Conceptual and perceptual false recognition
18. Perceptually- based false recognition of novel objects in amnesia: Effects of category size and similarity to category prototypes
19. Pathological false alarm rates following damage to the left frontal cortex
20. Neuropsychological mechanisms of false facial recognition following frontal lobe damage
21. False recognition and the right frontal lobe: A case study
22. Clusterin (apolipoprotein J) protein levels are increased in hippocampus and in frontal cortex in Alzheimer's disease
23. Tangles and plaques in nondemented aging and "preclinical" Alzheimer's disease
24. AIT-082, a novel purine derivative with neuroregenerative properties
25. AIT-082, a unique purine derivative, enhances nerve growth factor mediated neurite outgrowth from PC12 cells
26. Effect of AIT-082, a purine analog, on working memory in normal and aged mice
27. Severe frontal syndrome associated with infarcts of the left anterior cingulategyrus and the head of the right caudate nucleus. A clinico-pathological case
28. Differential effect of a dopaminergic agonist on prefrontal function intraumatic brain injury patients
29. D1 dopamine receptors in pre-frontal cortex: Involvement in working memory
30. A new rating scale for Alzheimer's disease
31. A phase II study in patients with Alzheimer's disease to assess the preliminary efficacy and maximum tolerated dose of rivastigmine (Exelon)
32. The effects of metrifonate on the cognitive, behavioral, and functional performance of Alzheimer's disease patients
33. The efficacy and safety of Donepezil in patients with Alzheimer's disease: Results of a US multicentre, randomized, double-blind, placebo-controlled trial
34. A 5-month, randomized, placebo-controlled trial of galantamine in AD
35. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease
36. A practical method for grading the cognitive state of patients for the clinician
37. PsyScope: A new graphic interactive environment for designing psychology experiments